Evaluation of In Vitro Models for Assessment of Human Intestinal Metabolism in Drug Discovery
出版年份 2020 全文链接
标题
Evaluation of In Vitro Models for Assessment of Human Intestinal Metabolism in Drug Discovery
作者
关键词
-
出版物
DRUG METABOLISM AND DISPOSITION
Volume 48, Issue 11, Pages 1169-1182
出版商
American Society for Pharmacology & Experimental Therapeutics (ASPET)
发表日期
2020-08-30
DOI
10.1124/dmd.120.000111
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Critical impact of drug-drug interactions via intestinal CYP3A in the risk assessment of weak perpetrators using physiologically based pharmacokinetic models
- (2020) Makiko Yamada et al. DRUG METABOLISM AND DISPOSITION
- Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Inter-correlations in the Human Small Intestine
- (2020) Narciso Couto et al. DRUG METABOLISM AND DISPOSITION
- Synthesis and evaluation of haloperidol ester prodrugs metabolically activated by human carboxylesterase
- (2019) Masato Takahashi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Gut Organoids: Mini-Tissues in Culture to Study Intestinal Physiology and Disease
- (2019) Mohammad Almeqdadi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- A novel in vitro experimental system for the evaluation of drug metabolism: Cofactor-supplemented permeabilized cryopreserved human hepatocytes (MetMax™ Cryopreserved Human Hepatocytes)
- (2018) Albert P. Li et al. DRUG METABOLISM AND DISPOSITION
- Cryopreserved human intestinal mucosal epithelium: a novel in vitro experimental system for the evaluation of enteric drug metabolism, P450 induction, and enterotoxicity
- (2018) Albert P. Li et al. DRUG METABOLISM AND DISPOSITION
- An update on the potential role of intestinal first-pass metabolism for the prediction of drug–drug interactions: the role of PBPK modeling
- (2018) Saeed Alqahtani et al. Expert Opinion on Drug Metabolism & Toxicology
- A Biomimetic Human Gut-on-a-Chip for Modeling Drug Metabolism in Intestine
- (2018) Yaqiong Guo et al. ARTIFICIAL ORGANS
- The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
- (2018) Li Di CURRENT DRUG METABOLISM
- The Yin–Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment
- (2018) Nadia Quignot et al. ARCHIVES OF TOXICOLOGY
- Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis
- (2018) Yi-Chen Chen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine
- (2018) Stefan Oswald PHARMACOLOGY & THERAPEUTICS
- Quantitative analysis of lab-to-lab variability in Caco-2 permeability assays
- (2017) Jong Bong Lee et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery
- (2017) Joachim Blanz et al. JOURNAL OF MASS SPECTROMETRY
- Can human experts predict solubility better than computers?
- (2017) Samuel Boobier et al. Journal of Cheminformatics
- Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination
- (2016) Christopher R. Jones et al. AAPS Journal
- Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models
- (2016) Sheila Annie Peters et al. CLINICAL PHARMACOKINETICS
- Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research
- (2016) Ming Li et al. Expert Opinion on Drug Metabolism & Toxicology
- Prediction of Mass Spectral Response Factors from Predicted Chemometric Data for Druglike Molecules
- (2016) Christopher J. Cramer et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
- (2016) N. Gobeau et al. PHARMACEUTICAL RESEARCH
- Plasma Protein Binding of Challenging Compounds
- (2015) Keith Riccardi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intestinal drug transporters: An overview
- (2012) Margarida Estudante et al. ADVANCED DRUG DELIVERY REVIEWS
- BDDCS Applied to Over 900 Drugs
- (2011) Leslie Z. Benet et al. AAPS Journal
- Predicting Drug – Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein
- (2011) Tatsuhiko Tachibana et al. CURRENT DRUG METABOLISM
- Interplay of Metabolism and Transport in Determining Oral Drug Absorption and Gut Wall Metabolism: A Simulation Assessment Using the “Advanced Dissolution, Absorption, Metabolism (ADAM)” Model
- (2011) A. S. Darwich et al. CURRENT DRUG METABOLISM
- Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human
- (2011) E. T. Williams et al. DRUG METABOLISM AND DISPOSITION
- Impact of Intestinal Glucuronidation on the Pharmacokinetics of Raloxifene
- (2011) K. Kosaka et al. DRUG METABOLISM AND DISPOSITION
- Physiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction
- (2011) M. Gertz et al. DRUG METABOLISM AND DISPOSITION
- Prediction of the Intestinal First-pass Metabolism of CYP3A and UGT Substrates in Humans from in vitro Data
- (2011) Haruka Nishimuta et al. Drug Metabolism and Pharmacokinetics
- The effect of grapefruit juice on drug disposition
- (2011) Michael J Hanley et al. Expert Opinion on Drug Metabolism & Toxicology
- Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment
- (2011) Simone Schadt et al. JOURNAL OF MASS SPECTROMETRY
- Human Tissue Ownership and Use in Research: What Laboratorians and Researchers Should Know
- (2010) M. J. Allen et al. CLINICAL CHEMISTRY
- Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data
- (2010) M. Gertz et al. DRUG METABOLISM AND DISPOSITION
- Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies
- (2010) Inge A M de Graaf et al. Nature Protocols
- Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: A study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10
- (2009) Takashi Mizuma INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Relative Importance of Intestinal and Hepatic Glucuronidation—Impact on the Prediction of Drug Clearance
- (2009) Helen E. Cubitt et al. PHARMACEUTICAL RESEARCH
- The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
- (2009) Sarah Shugarts et al. PHARMACEUTICAL RESEARCH
- Effect of Intestinal Glucuronidation in Limiting Hepatic Exposure and Bioactivation of Raloxifene in Humans and Rats
- (2008) Deepak Dalvie et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Grapefruit Juice-Drug Interaction Studies as a Method to Assess the Extent of Intestinal Availability: Utility and Limitations
- (2008) Michael Gertz et al. CURRENT DRUG METABOLISM
- Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data
- (2008) P. J. Kilford et al. DRUG METABOLISM AND DISPOSITION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now